ETR:SHL Siemens Healthineers Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Siemens Healthineers AG Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €38.40 +0.40 (+1.05 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range€37.69Now: €38.40▼€38.4050-Day Range€36.38MA: €39.65▼€45.6452-Week Range€28.50Now: €38.40▼€47.27Volume3.29 million shsAverage VolumeN/AMarket Capitalization$38.38 billionP/E Ratio25.98Dividend Yield2.13%BetaN/A ProfileAnalyst RatingsChartCompetitorsHeadlines Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions. The Advanced Therapies segment offers advanced therapy products, services, and solutions to the therapy departments of healthcare providers. The Diagnostics segment provides diagnostic products and services, including a range of testing applications, in the areas of laboratory, point of care, and molecular diagnostics. Siemens Healthineers AG is based in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.Read More Beat the Market (BTM) Rank™ 3.2 Analyst's Opinion Consensus RatingSiemens Healthineers has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 7 buy ratings, 7 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of €42.64, Siemens Healthineers has a forecasted upside of 11.0% from its current price of €38.40.Amount of Analyst CoverageSiemens Healthineers has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Community Rank Outperform VotesSiemens Healthineers has received 180 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSiemens Healthineers has received 280 “underperform” votes. (Add your “underperform” vote.)Community SentimentSiemens Healthineers has received 60.87% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote “Outperform” if you believe SHL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldSiemens Healthineers pays a meaningful dividend of 2.13%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSiemens Healthineers does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Siemens Healthineers is 54.13%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Siemens Healthineers insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Siemens Healthineers is 25.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.91.Price to Earnings Ratio vs. SectorThe P/E ratio of Siemens Healthineers is 25.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.05.Price to Book Value per Share RatioSiemens Healthineers has a P/B Ratio of 3.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.2Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.49 out of 5 stars Industry, Sector and Symbol Stock Exchange ETR Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolETR:SHL Previous Symbol CUSIPN/A CIKN/A Webwww.healthcare.siemens.de Phone49 69 6682 6602Debt Debt-to-Equity Ratio56.67 Current Ratio1.31 Quick Ratio0.79Price-To-Earnings Trailing P/E Ratio25.98 Forward P/E Ratio20.41 P/E GrowthN/A Sales & Book Value Annual Sales$14.73 billion Price / Sales2.61 Cash Flow€0.75 per share Price / Cash Flow51.08 Book Value€9.72 per share Price / Book3.95Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees50,300 Outstanding Shares999,348,992Market Cap$38.38 billion Next Earnings DateN/A OptionableNot Optionable €38.40 +0.40 (+1.05 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SHL News and Ratings via Email Sign-up to receive the latest news and ratings for SHL and its competitors with MarketBeat's FREE daily newsletter. Siemens Healthineers (ETR:SHL) Frequently Asked Questions How has Siemens Healthineers' stock been impacted by Coronavirus (COVID-19)? Siemens Healthineers' stock was trading at €33.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SHL shares have increased by 14.3% and is now trading at €38.40. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Siemens Healthineers? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 2 sell ratings, 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Siemens Healthineers. What price target have analysts set for SHL? 16 Wall Street analysts have issued 12 month price objectives for Siemens Healthineers' shares. Their forecasts range from €32.00 to €52.00. On average, they expect Siemens Healthineers' share price to reach €42.64 in the next year. This suggests a possible upside of 11.0% from the stock's current price. View analysts' price targets for Siemens Healthineers. Who are some of Siemens Healthineers' key competitors? Some companies that are related to Siemens Healthineers include Sartorius (SRT), Carl Zeiss Meditec (AFX), Legend Biotech (BNR), Legend Biotech (GTH), Profound Medical (PRN), Renalytix Ai (RENX), Arch Capital Group (AWH), Akumin (AKU), MaxCyte (MXCT), Exagen (XGN), Yourgene Health (YGEN), Palatin Technologies (PTN), Oncimmune (ONC), Senseonics (SENS) and Lexagene (LXG). View all competitors. What other stocks do shareholders of Siemens Healthineers own? Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Broadcom (AVGO), Illumina (ILMN), Moderna (MRNA), Koninklijke Philips (PHIA), Regeneron Pharmaceuticals (REGN), Adobe (ADBE), Applied Materials (AMAT), Bio-Rad Laboratories (BIO) and Cerner (CERN). Who are Siemens Healthineers' key executives? Siemens Healthineers' management team includes the following people: Dr. Jochen Schmitz, CFO & Member of Management Board (Age 53)Mr. Michael Reitermann, Chief Markets & Diagnostics Officer and Member of Management Board (Age 57)Mr. Florian Flossmann, Head of Investor Relations What is Siemens Healthineers' stock symbol? Siemens Healthineers trades on the ETR under the ticker symbol "SHL." What is Siemens Healthineers' stock price today? One share of SHL stock can currently be purchased for approximately €38.40. How big of a company is Siemens Healthineers? Siemens Healthineers has a market capitalization of $38.38 billion and generates $14.73 billion in revenue each year. Siemens Healthineers employs 50,300 workers across the globe. What is Siemens Healthineers' official website? The official website for Siemens Healthineers is www.healthcare.siemens.de. How can I contact Siemens Healthineers? The company can be reached via phone at 49 69 6682 6602. This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
